ADC Therapeutics SA Price to Sales Ratio 2019-2022 | ADCT
Historical PS ratio values for ADC Therapeutics SA (ADCT) over the last 10 years. The current P/S ratio for ADC Therapeutics SA as of June 28, 2022 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| ADC Therapeutics SA P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2022-06-28 |
7.74 |
|
7.39 |
| 2022-03-31 |
14.69 |
$1.05 |
14.03 |
| 2021-12-31 |
20.20 |
$0.44 |
45.71 |
| 2021-09-30 |
27.16 |
$0.22 |
123.27 |
| 2021-06-30 |
24.35 |
$0.05 |
496.90 |
| 2021-03-31 |
24.41 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.000B |
$0.034B |
|
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
|
